Skip to main content

Nierenersatztherapie: Derzeitige technische Möglichkeiten und Zukunftsaspekte

  • Conference paper
Verhandlungen der Deutschen Gesellschaft für Innere Medizin

Part of the book series: Verhandlungen der Deutschen Gesellschaft für Innere Medizin ((VDGINNERE,volume 95))

  • 39 Accesses

Zusammenfassung

Weltweit werden zur Zeit ca. 250 000 Patienten mit terminaler Niereninsuffizienz durch eine Organersatztherapie erfolgreich behandelt. In der Bundesrepublik Deutschland liegt diese Zahl bei etwa 20 000. Die weit überwiegende Mehrzahl der Patienten wird mit der Hämodialyse behandelt. Alternativen sind Peritonealdialyse und Transplantation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Baldamus CA, Ernst W, Frei U, Koch KM (1982) Sympathetic and hemodynamic response to volume removal during different forms in renal replacement therapy. Nephron 31:324

    Article  PubMed  CAS  Google Scholar 

  2. Brunner FP, Wing AJ, Dykes SR, Brynger HOA, Fassbinder W, Selwood NH (1989) International review of renal replacement therapy: Strategies and results. Replacement of Renal Function by Dialysis. Kluwer Academic, Dordrecht, Holland, pp 697–719

    Book  Google Scholar 

  3. Gejyo F, Yamada T, Odani S, Nakagawa Y, Kunimoto T, Kataoka H, Suzuki M, Hirasawa Y, Shirahama T, Cohen AS, Schmid K (1985) A new form of amyloid protein associated with hemodialysis was identified as β2-microglobulin. Biochem Biophys Res Commun 129:701

    Article  PubMed  CAS  Google Scholar 

  4. Gorevic PC, Casey TT, Stone WJ, Di Raimondo CR, Prelli FC, Frangione B (1985) Beta-2-microglobulin is an amyloidogenic protein in man. J Clin Invest 76:2425

    Article  PubMed  CAS  Google Scholar 

  5. Graeffe U, Milutinovich J, Follette WC, Vizzo JE, Babb AL, Scribner BH (1978) Less dialysis-induced morbidity and vascular instability with bicarbonate in dialysate. Ann Intern Med 88:332

    Google Scholar 

  6. Haas G (1925) Dialysieren des strömenden Blutes am Lebenden. (Dialysis of the circulating blood in vivo). Klin Wochenschr 4:13 (in German)

    Article  CAS  Google Scholar 

  7. Kolff WJ (1946) De Kunstmatige Nier. (The artificial kidney). MD Thesis, University of Groningen, The Netherlands, Kampen. JH Kok NV (in Dutch)

    Google Scholar 

  8. Kolff WJ (1954) Dialysis in treatment of uremia. Arch Intern Med 94:142

    Article  CAS  Google Scholar 

  9. Leber HW, Wizemann V, Goubeaud G, Rawer P, Schütterle G (1978) Simultaneous hemofiltration/hemodialysis: an effective alternative to hemofiltration and conventional hemodialysis in the treatment of uremic patients. Clin Nephrol 9:115

    PubMed  CAS  Google Scholar 

  10. Lonnemann G, van der Meer JWM, Endres S, Shaldon S, Koch KM, Dinarello CA (1988) Induction and removal of tumor necrosis factor and interleukin-1 during in vitro hemodialysis. Kidney Int 33:229

    Article  Google Scholar 

  11. Lonnemann G (1988) In vitro Untersuchungen zu Mechanismen der Interleukin-1-Produktion während der Hämodialyse. Mitteilungen der Arbeitsgemeinschaft für Klinische Nephrologie, Vandenberg & Ruprecht, Göttingen, S15

    Google Scholar 

  12. Mion CM, Hegstrom RM, Boen ST (1964) Substitution of sodium acetate for sodium bicarbonate in the bath fluid for hemodialysis. Trans Am Soc Artif Intern Organgs 10:110

    CAS  Google Scholar 

  13. Quellhorst E, Rieger J, Doht B, Beckmann H, Jacob I, Kraft B, Mietzsch G, Scheler F (1976) Treatment of chronic uremia by an ultrafiltration kidney: first clinical exprience. Proc Eur Dial Transplant Assoc 13:314

    Google Scholar 

  14. Schmidt M, Baldamus CA, Schoeppe W (1984) Backfiltration in hemodialyzers with highly permeable membranes. Blood Purif 2:108

    Article  Google Scholar 

  15. Scribner BH, Babb AL (1982) Chronic hemodialysis in Seattle 1960–1966, part II. Dial Transplant 11:324

    Google Scholar 

  16. Shaldon S, Baillod RA, Comty C, Oakley J, Sevitt L (1964) 18 months experience with a nurse-patient operated chronic dialysis unit. Proc Eur Dial Transplant Assoc 1:233

    Google Scholar 

  17. Shaldon S, Deschodt G, Branger B, Granolleras C, Baldamus CA, Koch KM, Lysaght MJ, Dinarello CA (1985) Hemodialysis hypotension: the interleukin hypothesis restated. Proc Eur Dial Transplant Assoc Eur Ren Assoc 22:229

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer-Verlag, Berlin Heidelberg

About this paper

Cite this paper

Baldamus, C.A. (1989). Nierenersatztherapie: Derzeitige technische Möglichkeiten und Zukunftsaspekte. In: Miehlke, K. (eds) Verhandlungen der Deutschen Gesellschaft für Innere Medizin. Verhandlungen der Deutschen Gesellschaft für Innere Medizin, vol 95. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83864-4_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-83864-4_14

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-51437-4

  • Online ISBN: 978-3-642-83864-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics